Trial Profile
Phase II Study of bi-weekly Paclitaxel (TAXOL) for fluorouracil resistant advanced and recurrent Gastric Cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2009
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 08 Jun 2009 New trial record.